Form 8-K - Current report:
SEC Accession No. 0001104659-16-144652
Filing Date
2016-09-14
Accepted
2016-09-14 16:31:33
Documents
5
Period of Report
2016-09-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a16-18432_18k.htm 8-K 43835
2 EX-10.1 a16-18432_1ex10d1.htm EX-10.1 723351
3 EX-10.2 a16-18432_1ex10d2.htm EX-10.2 105590
4 EX-99.1 a16-18432_1ex99d1.htm EX-99.1 18081
5 GRAPHIC g184321mmi001.gif GRAPHIC 6650
  Complete submission text file 0001104659-16-144652.txt   901644
Mailing Address 64 SIDNEY ST. CAMBRIDGE MA 02139
Business Address 64 SIDNEY ST. CAMBRIDGE MA 02139 7349305555
Vericel Corp (Filer) CIK: 0000887359 (see all company filings)

EIN.: 943096597 | State of Incorp.: MI | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35280 | Film No.: 161885378
SIC: 2836 Biological Products, (No Diagnostic Substances)